Cargando…

Modelling the therapeutic dose range of single low dose primaquine to reduce malaria transmission through age-based dosing

BACKGROUND: Low-dose primaquine is a key candidate for use in malaria transmission reduction and elimination campaigns such as mass drug administration (MDA). Uncertainty about the therapeutic dose range (TDR) required for general and paediatric populations challenge the implementation of the World...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayes, Daniel Joseph, Banda, Clifford George, Chipasula-Teleka, Alexandra, Terlouw, Dianne Janette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385020/ https://www.ncbi.nlm.nih.gov/pubmed/28390397 http://dx.doi.org/10.1186/s12879-017-2378-9

Ejemplares similares

Low-dose primaquine to reduce the transmission of P. falciparum malaria: a roadmap update
por: Chen, Ingrid, et al.
Publicado: (2014)

An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia
por: Leang, Rithea, et al.
Publicado: (2016)

Higher-Dose Primaquine to Prevent Relapse of Plasmodium vivax Malaria
por: Watson, James A., et al.
Publicado: (2022)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria
por: Mukaka, Mavuto, et al.
Publicado: (2023)

Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria
por: Dondorp, Arjen M.
Publicado: (2013)

Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012)

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria
por: Taylor, Walter Robert, et al.
Publicado: (2021)

Single dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission in Cambodia: An open-label randomized trial
por: Lin, Jessica T., et al.
Publicado: (2017)

Pharmacovigilance for single low-dose primaquine: a practical approach
por: Poirot, Eugenie, et al.
Publicado: (2014)

Pharmacokinetics of single-dose primaquine in patients with chronic kidney dysfunction
por: Kulkarni, Shaunak P., et al.
Publicado: (2013)

Developing regional weight-for-age growth references for malaria-endemic countries to optimize age-based dosing of antimalarials
por: Hayes, Daniel J, et al.
Publicado: (2015)

Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria – a proposed model-derived age-based regimen for sub-Saharan Africa
por: Taylor, W. Robert, et al.
Publicado: (2018)

Ethics, Economics, and the Use of Primaquine to Reduce Falciparum Malaria Transmission in Asymptomatic Populations
por: Lubell, Yoel, et al.
Publicado: (2014)

Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis
por: Stepniewska, Kasia, et al.
Publicado: (2020)

Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
por: Gogtay, NJ, et al.
Publicado: (2021)

Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)

Comparative single dose pharmacokinetics and metabolism of racemic primaquine and its enantiomers in human volunteers
por: Khan, Washim, et al.
Publicado: (2022)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
por: Mac Donald-Ottevanger, M Sigrid, et al.
Publicado: (2017)

Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms
por: Aguiar, Anna Caroline C., et al.
Publicado: (2017)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

Factors affecting haemoglobin dynamics in African children with acute uncomplicated Plasmodium falciparum malaria treated with single low-dose primaquine or placebo
por: Onyamboko, Marie A., et al.
Publicado: (2023)

CYP2D6 Polymorphisms and the Safety and Gametocytocidal Activity of Single-Dose Primaquine for Plasmodium falciparum
por: Pett, Helmi, et al.
Publicado: (2019)

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2015)

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2014)

Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2018)

Safety of a single low-dose of primaquine in addition to standard artemether-lumefantrine regimen for treatment of acute uncomplicated Plasmodium falciparum malaria in Tanzania
por: Mwaiswelo, Richard, et al.
Publicado: (2016)

Safety and Efficacy of Adding a Single Low Dose of Primaquine to the Treatment of Adult Patients With Plasmodium falciparum Malaria in Senegal, to Reduce Gametocyte Carriage: A Randomized Controlled Trial
por: Tine, Roger C., et al.
Publicado: (2017)

Primaquine plus artemisinin combination therapy for reduction of malaria transmission: promise and risk
por: John, Chandy C.
Publicado: (2016)

Safety and tolerability of single low-dose primaquine in a low-intensity transmission area in South Africa: an open-label, randomized controlled trial
por: Raman, Jaishree, et al.
Publicado: (2019)

Imported Tertian Malaria Resistant to Primaquine
por: Na, Dong Jib, et al.
Publicado: (1999)

Rational malaria chemoprophylaxis – The position of primaquine
por: Baird, J. Kevin
Publicado: (2017)

The tolerability of single low dose primaquine in glucose-6-phosphate deficient and normal falciparum-infected Cambodians
por: Dysoley, Lek, et al.
Publicado: (2019)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
por: Gonçalves, Bronner P., et al.
Publicado: (2016)

High-Dose Primaquine Induces Proximal Tubular Degeneration and Ventricular Cardiomyopathy Linked to Host Cells Mitochondrial Dysregulation
por: Rabiablok, Atthasit, et al.
Publicado: (2023)

Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
por: Vantaux, Amélie, et al.
Publicado: (2020)

Study protocol for a randomised controlled double-blinded trial of the dose-dependent efficacy and safety of primaquine for clearance of gametocytes in children with uncomplicated falciparum malaria in Uganda
por: Eziefula, Alice Chijioke, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gtgr8kv3jmhataegu0di6losrf